Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|July 1, 2016
The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicalityChad Ruoff, David Rye
Current Pharmaceutical Design|April 12, 2011
Hypocretin antagonists in insomnia treatment and beyondChad Ruoff, Michelle Cao, Christian Guilleminault
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 6, 2025
Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatmentLogan D Schneider, Alyssa Cairns, Chad Ruoff, et al.
Sleep Medicine|May 26, 2024
Clinical considerations in the treatment of idiopathic hypersomniaMichael J Thorpy, Lois Krahn, Chad Ruoff, et al.
Sleep Medicine|October 22, 2024
Connecting clinicians and patients: The language of narcolepsyLucie Barateau, Anne Marie Morse, Simerpal K Gill, et al.
Neurology and Therapy|September 27, 2023
Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A CommentaryRussell Rosenberg, Rogelio Braceras, Wayne Macfadden, et al.
Sleep Medicine|July 20, 2025
Diagnostic performance of Large Language Models (LLMs) compared with physicians in sleep medicineAnshum Patel, Chad Ruoff, Scott A Helgeson, et al.
Sleep Medicine|April 29, 2014
The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findingsJed Black, Nancy L Reaven, Susan E Funk, et al.
Pageof 2